The role of CD95 and CD95 ligand in cancer

ME Peter, A Hadji, AE Murmann, S Brockway… - Cell death & …, 2015 - nature.com
Abstract CD95 (Fas/APO-1) and its ligand, CD95L, have long been viewed as a death
receptor/death ligand system that mediates apoptosis induction to maintain immune …

MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis

S Shirjang, B Mansoori, S Asghari, PHG Duijf… - Free Radical Biology …, 2019 - Elsevier
To protect tissues and the organism from disease, potentially harmful cells are removed
through programmed cell death processes, including apoptosis and necroptosis. These …

MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death

R Schickel, B Boyerinas, SM Park, ME Peter - Oncogene, 2008 - nature.com
Micro (mi) RNAs are small, highly conserved noncoding RNAs that control gene expression
post-transcriptionally either via the degradation of target mRNAs or the inhibition of protein …

New insights into apoptosis signaling by Apo2L/TRAIL

F Gonzalvez, A Ashkenazi - Oncogene, 2010 - nature.com
Apoptosis ligand 2 tumor necrosis factor (TNF)-related apoptosis-inducing ligand
(Apo2L/TRAIL) belongs to a small subset of proapoptotic protein ligands in the TNF …

Death receptors in chemotherapy and cancer

KM Debatin, PH Krammer - Oncogene, 2004 - nature.com
Apoptosis, the cell's intrinsic death program, is a key regulator of tissue homeostasis. An
imbalance between cell death and proliferation may result in tumor formation. Also, killing of …

Let-7 expression defines two differentiation stages of cancer

S Shell, SM Park, AR Radjabi… - Proceedings of the …, 2007 - National Acad Sciences
The early phases of carcinogenesis resemble embryonic development, often involving the
reexpression of embryonic mesenchymal genes. The NCI60 panel of human tumor cell lines …

Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression

ME Peter - Cell cycle, 2009 - Taylor & Francis
Micro (mi) RNAs are emerging as important regulators of cellular differentiation, their
importance underscored by the fact that they are often dysregulated during carcinogenesis …

Rapamycin pre-treatment protects against apoptosis

B Ravikumar, Z Berger, C Vacher… - Human molecular …, 2006 - academic.oup.com
Macroautophagy (generally referred to as autophagy) mediates the bulk degradation of
cytoplasmic contents, including proteins and organelles, in lysosomes. Rapamycin, a …

[HTML][HTML] The CD95 receptor: apoptosis revisited

ME Peter, RC Budd, J Desbarats, SM Hedrick… - Cell, 2007 - cell.com
The CD95 Receptor: Apoptosis Revisited: Cell Skip to Main Content Advertisement Cell This
journal offers authors two options (open access or subscription) to publish research Submit Log …

CD95 ligand induces motility and invasiveness of apoptosis‐resistant tumor cells

BC Barnhart, P Legembre, E Pietras, C Bubici… - The EMBO …, 2004 - embopress.org
The apoptosis‐inducing death receptor CD95 (APO‐1/Fas) controls the homeostasis of
many tissues. Despite its apoptotic potential, most human tumors are refractory to the …